- Iraqi Cancer Board (2016). Results of the Iraqi Cancer Registry 2015. Baghdad, Iraqi Cancer Registry Center, Ministry of Health, 2018.
- Annual Statistical Report 2016. Planning Directorate, Ministry of Health/ Environment, Republic of Iraq, 2017. Available from: https://moh.gov.iq/ upload/up le/ar/513.pdf.
- Alwan, N, Kerr D, Al-Okati D, et al. Comparative study on the clinic-pathological profiles of breast cancer among Iraqi and British patients. The Open Public Health Journal. 2018; (11): 177–191
- Alwan NAS, Tawfeeq F, Maallah M et al:The Stage of Breast Cancer at the Time of Diagnosis: Correlation with the Cinicopathological Findings among Iraqi Patients. J Neoplasm, 2017; Vol. 2 (3:22); 1-10.
- Alwan NAS, Mualla F, Naqash M et al: Clinical and Pathological Characteristics of Triple Positive Breast Cancer among Iraqi Patients, Gulf Journal of Oncology, 2017; 25: 6-15.
- Alwan NAS.,Tawfek FN.,Mallah NAC, Demographic and clinical profiles of female Patients diagnosed with breast cancer in Iraq. Journal of Contemporary Medical Science, 2019; 5 (1): 14-19.
- Alwan NAS. Tumor Characteristics of Female Breast Cancer: Pathological review of Mastectomy Specimens Belonging to Iraqi Patients .World Journal of Breast Cancer Research, 2018; 1 (1): 1-3.
- Rosai and Ackerman''s Surgical Pathology, Elsevier, eleventh edition, 2018, chapter36 Breast pp (1434-1527)
- Alwan N: Establishing Guidelines for Early Detection of Breast Cancer in Iraq. Int .J. of Advanced Research. 2015; 3 (12): 539-555
- Sankar R, Alwan N & Denny L: “How Can We Improve Survival from Breast Cancer in Developing Countries?" Future Medicine, Breast Cancer Management, 2013, 2 (3): 179-183.
- Alwan NAS, Kerr D. Cancer Control in War-Torn Iraq, The Lancet Oncology, 2018; 19 (3): 291-292
- Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes dealing with the diversity of breast cancer: Highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011, Ann Oncol. 2011; 22 (8):1747-1736
- Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E,Zackrisson S, Cardoso F. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology. 2015 Sep 1; 26 (suppl_5):v8-30.
- Alwan NAS. Breast Cancer Among Iraqi Women: Preliminary Findings From a Regional Comparative Breast Cancer Research Project. Journal of Global Oncology, 2016; 2 (5): 255-258.
- Alwan NAS and Al-Attar: Evaluating the Effect of an Educational Teaching Model on the Knowledge about Breast Cancer among Female University Students in Iraq., JJ Cancer Sci. Res. 2016, 2 (1): 026.
- Alwan NAS, Alattar W, Mallah N, Hassoun T: Baseline Needs Assessment for Breast Cancer Awareness and Management among Paramedical Health Care Providers in Iraq. International Journal of Science and Research (IJSR), 2017; 6 (7): 1515-1520.
- Alwan NAS, Al-Attar WM, Al Mallah N. Baseline Needs Assessment for Breast Cancer Awareness among Patients in Iraq, International Journal of Science and Research (IJSR), 2017; 6 (1): 2088 – 2093.
- Alwan NAS: Clinical and Pathological Characteristics of Familial Breast Cancer in Iraq, Chronicle Journal of Cancer Science, 2017; 1 (1): 002.
- Alwan NAS. Family History among Iraqi Patents Diagnosed with Breast Cancer, IJSR, 2017; 6 (2): 868-872.
- Majid RA, Mohammed HA, Saeed HM, Safar BM, Rashid RM, Hughson MD. Breast cancer in kurdish women of northern Iraq: incidence, clinical stage, and case control analysis of parity and family risk. BMC women''s health. 2009; 9 (1):33.
- Alwan NAS, Tawfeeq FN, Muallah FH. Breast Cancer Subtypes among Iraqi Patients: Identified By Their ER, PR and HER2 Status. Fac Med Baghdad, 2017; 59 (4): 304-307.
- Alawad AS, ALkathum MA, Alwahed AA. A Retrospective Study of Relapsed Breast Cancer Cases During Follow-Up in Merjan. Medical Journal of Babylon. 2009;6 (1): 130-7.
- Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clinical Medicine & Research. 2009 Jun 1; 7 (1-2):4-13.
- Anthony FY, Yadav NU, Lung BY, Eaton AA, Thaler HT, Hudis CA, Dang CT, Steingart RM. Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer. Breast cancer research and treatment. 2015; 1; 149(2):489-95.
- Talima S, Kassem H, Kassem N. Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection. Breast Cancer. 2019; 15;26 (2):154-63.
- Tlefih AJ. Non-Metastatic Breast Cancer: Clinical Presentation and Patterns of Surgical Treatment. Al-Kindy College Medical Journal. 2009; 5 (1):40-6.
- Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. Journal of the National Cancer Institute. 2002; 3;94 (7):490-6.
- El Saghir N, Khalil MK, Eid T, et al. Trends in epidemiology and management of breast cancer in developing Arab countries: A literature and registry analysis. International Journal of Surgery, 2007; 226-233.
- Lazaraviciute G, Chaturvedi S. Mastectomy—A Critical Review. Open Journal of Clinical Diagnostics, 2017; 7:58-66.
- American Society of Clinical Oncology. The state of cancer care in America. A report by the American Society of Clinical Oncology. J. Oncol. Practice, 2014; 10: 119-142.
|